Results 111 to 120 of about 68,477 (247)
Retinoblastoma: The Evidence Does Matter
Cellular Oncology, 2009 Nadia L. Prigoda-Leea +6 more
doaj +1 more source
Elevated Poly-(ADP-Ribose)-Polymerase Activity Sensitizes Retinoblastoma-Deficient Cells to DNA Damage–Induced Necrosis [PDF]
, 2009 Huiping Liu +3 more
openalex +1 more source
Head &Neck, Volume 48, Issue 1, Page 246-260, January 2026.ABSTRACT Background Oral leukoplakia (OL) represents the most common oral potentially malignant disorder globally, with highly variable reported malignant transformation (MT) rates creating challenges for evidence‐based clinical management. Objective To systematically synthesize evidence on MT prevalence in OL and evaluate potential predictive ...
Mohammed Taib Fatih +13 more
wiley +1 more source
Driving Innovation: The Impact of National Health Policies on Optometry Research in East Asia
The International Journal of Health Planning and Management, Volume 41, Issue 1, Page 37-46, January 2026.ABSTRACT This study examines the optometric research landscape in three East Asian countries—China, Japan, and Korea—analysing how research trends align with each country's national health strategies. By evaluating published articles and reviews from national journals between 2006 March 2025, we identify key areas of focus, including paediatric ...
Jihye Ahn, Moonsung Choi
wiley +1 more source
Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome
International Journal of Cancer, Volume 158, Issue 1, Page 243-256, 1 January 2026.What's new? Lynch syndrome (LS) significantly increases lifetime cancer risk, necessitating innovative approaches for risk stratification. Current risk assessment methods, however, fail to integrate data from different biological systems, which may be influenced by lifestyle factors.
Minta Kärkkäinen +9 more
wiley +1 more source
Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention
MedComm, Volume 7, Issue 1, January 2026.The review manuscript examines the molecular pathogenesis, screening, prevention advances, and evolving targeted therapies in breast cancer. It highlights the integration of AI and multiomics for precision prevention and personalized treatment, pointing toward future directions in equitable cancer care.
Huijun Lei +7 more
wiley +1 more source
Melanoma: Pathogenesis and Targeted Therapy
MedComm, Volume 7, Issue 1, January 2026.The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu +5 more
wiley +1 more source
Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide [PDF]
, 2013 Deborah Biasoli +7 more
openalex +1 more source
Otolaryngology–Head and Neck Surgery, Volume 174, Issue 1, Page 57-76, January 2026.Abstract Objective To assess patient outcomes with regard to swallowing, feeding tube dependence, tracheostomy use, pain levels, and recovery metrics between transoral robotic surgery and (chemo)radiotherapy. Data Sources Medline, EMBASE, Web of Science Core Collection, and the Cochrane Library.
Simpson Shiu Chung Tam +10 more
wiley +1 more source
<p>MicroRNA-506 regulates apoptosis in retinoblastoma cells by targeting sirtuin 1</p>
, 2019 Zhidu Song +4 more
openalex +2 more sources